Updates in the Management of Relapsing Multiple Sclerosis

EP. 1: 2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 16th 2020

EP. 2: Use of MRI in Diagnosing Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 23rd 2020

EP. 3: Misdiagnosis of Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 25th 2020

EP. 4: Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 28th 2020

EP. 5: Challenges in Optimally Treating Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 31st 2020

EP. 6: QoL Issues in the Management of Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 1st 2021

EP. 7: Multiple Sclerosis Fatigue

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 4th 2021

EP. 8: TRIUMPHANT-MS Trial: Fatigue in MS

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 5th 2021

EP. 9: OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 12th 2021

EP. 10: Strategies for Choosing Initial Therapy in MS

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 15th 2021

EP. 11: Anti-CD20 Monoclonal Antibodies for Treatment of RMS

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 18th 2021

EP. 12: Cladribine for Treatment of RMS

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 20th 2021

EP. 13: S1P Receptor Modulators for Treatment of RMS

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 21st 2021

EP. 14: Fumarates for Treatment of RMS

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 26th 2021

EP. 15: The Future of Managing Multiple Sclerosis

ByFred Lublin, MD,Patricia K. Coyle, MD,Scott Newsome, DO, MSCS, FAAN,Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

February 2nd 2021

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Daridorexant Provides Relief for Insomnia in Women During Menopausal Transition

Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity

RELIEV-CM Pilot Study Data Further Supports ShiraTronics’ Neuromodulation Device to Treat Chronic Migraine

New Study Finds Link Between Gut Hormone GLP-1 and NMOSD Symptoms, Paving Way for Targeted Treatments

Optimizing Speech and Movement Therapy to Improve Motor and Nonmotor Symptoms of Parkinson Disease: Cynthia Fox, PhD, CCC-SLP

© 2025 MJH Life Sciences^®

All rights reserved.